Pregled bibliografske jedinice broj: 1091699
UHPLC Study on the Degradation Profiles of Olopatadine Hydrochloride in Eye Drops Subjected to Heat and Filtration Methods of Sterilisation
UHPLC Study on the Degradation Profiles of Olopatadine Hydrochloride in Eye Drops Subjected to Heat and Filtration Methods of Sterilisation // Chromatographia, 77 (2014), 15-16; 1067-1080 doi:10.1007/s10337-014-2712-y (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1091699 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
UHPLC Study on the Degradation Profiles of
Olopatadine Hydrochloride in Eye Drops
Subjected to Heat and Filtration Methods of
Sterilisation
Autori
Munjas Jurkic, L. ; Buratovic, M. ; Valentic, I. ; Stanfel, D.
Izvornik
Chromatographia (0009-5893) 77
(2014), 15-16;
1067-1080
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
UHPLC, sterilisation method, sterilisation by filtration, terminal sterilisation, Olopatadine hydrochloride, degradation products
Sažetak
A validated ultra-high performance liquid chromatography (UHPLC) method has been proposed, validated and used for the determination of olopatadine hydrochloride degradation products in olopatadine 1 mg mL-1 eye drops solution under the influence of two different sterilisation methods, heating and filtration, with good precision and accuracy. We found that the heat sterilization method yields a higher content of olopatadine hydrochloride degradation products in eye drops compared to unsterilized drug product or drug product sterilized by filtration, except for α- hydroxy olopatadine impurity, which remains stable with time and applied sterilization method. Contents of olopatadine related compound B shows a higher increase (from <0.005% to 0.044%) when sterilised by heating than when subjected to aging and sterilization by filtration (increase up to 0.011%). Similarly, total amount of all impurities is also increased from 0.13% to 0.49% when the drug product is sterilised by heating instead of filtration (up to 0.39%). Content of olopatadin related compound B and of all impurities is increased by aging probably through thermal and oxidative degradation. Forced degradation studies were correlated with the sterilisation study and possible degradation pathways were identified. Olopatadine shows strong degradation under oxidative and moderate degradation under photolytic environment, with the olopatadine related compound B as the main degradation product. Sterilization of eye drops solution by filtration is recommended.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Farmacija
Napomena
Danijela Štanfel (glavni autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus